We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Summit Therapeutics Plc | LSE:SUMM | London | Ordinary Share | GB00BN40HZ01 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 20.50 | 18.00 | 23.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
23/5/2017 15:02 | fortunately I fly back to the UK early on the 18th so plan to be there. 2 long haul flights so likely to be sub par! | freedosh | |
23/5/2017 14:55 | I agree with all the last 3 postings & good to see freedosh responding & hopefully he will be at the next AGM with his incisive questions. Summit are now building a very strong team & shows their confidence in their two developments.The current share price does not properly reflect where Summit are but I am sure with time we will soon see a significant increase. Looking forward to the AGM. | chrisatrdg | |
23/5/2017 13:48 | Dr David Roblin..... ""was involved in the successful development of a number of antibiotics"! Well, with his record of successes he wouldn't want to be associated with a failure now would he? Bet he has checked Summit out and happy with how things are going! Indeed, so am I. | poseidon2 | |
23/5/2017 13:35 | "Dr David Roblin MD, FRCP, FFPM, FMedSci .... was involved in the successful development of a number of antibiotics" So speculation over as to whether Summit will farm out RZD P3 to a third party .. whatever the funding, they're gearing up to do everything in house. | hugus maximus | |
23/5/2017 13:11 | Excellent highly qualified appointments, IMO. | freedosh | |
23/5/2017 13:01 | 23rd May 2017 Summit Announces Key Appointments to Strengthen Research & Development Team | chrisatrdg | |
22/5/2017 15:14 | Look forward to the report back. Can't attend as will be away. | waterloo01 | |
22/5/2017 15:10 | I'm planning on attending the AGM as well & did so last year. | chrisatrdg | |
22/5/2017 13:13 | I'm planning on attending the AGM FM. | hugus maximus | |
22/5/2017 11:46 | What is everyone's target? | sorrento06 | |
22/5/2017 11:11 | As I'm still fully invested and confident in Summit delivering to plan now I'll be going to the AGM on the 18th July. Anyone else going? It would be great to meet up. "The Annual General Meeting will be held at 11:00am BST on Tuesday, 18 July 2017 at the Milton Park Innovation Centre, 99 Park Drive, Abingdon, Oxfordshire, OX14 4RY, UK" | freemoney2 | |
19/5/2017 16:18 | NASDAQ chart looks a whole lot better than AIM. Would have hoped for a bit more reflected buying on AIM this afternoon? | tightfist | |
19/5/2017 16:06 | Hi All - I am still staying positive & would be surprised if we went down to £1.50 in May or June nor even July but for me Summer ends in August (excluding Indian Summer in Sept)by which time I am expecting a RDZ deal if not share price may well reduce from todays share price I note we have currently some blue today on AIM & NASDAQ up 7.03% on NLS share vol. of 3,150. However I do not have a crystal ball but provided the science remains solid still good to hold. | chrisatrdg | |
19/5/2017 09:37 | waterloo01 remember we don't have summers here in the UK as we have a nice Thursday afternoon followed by a few days when it doesn't rain | football | |
19/5/2017 09:35 | Don't think they will wait too long before deciding on RDZ (they have said by summer). Re FDA, if anything SRPT opened the door but be thankful SUMM are doing a larger and more robust study that as Glyn has said in order to make the FDA's decision an easy one! (Assuming it works!). | waterloo01 | |
19/5/2017 07:45 | Thanks Waterloo, I hope this doesn't leave scorched earth in the FDA DMD space when we get there - hopefully!If we don't get newsflow (RDZ please...) or access new money through all those conferences, I can see us drifting back to 150p over the next month or two. | tightfist | |
17/5/2017 10:02 | All decent events but ASM microbe sticks out for me as it's the key event in the sector. Hopefully news at or around this time. | waterloo01 | |
17/5/2017 09:50 | Maybe some news is coming in June seeing most of them are in that month | football | |
17/5/2017 09:48 | 7 New conferences listed by Summit today looks exciting: | chrisatrdg | |
17/5/2017 08:55 | RDZ next steps can't be far off? | waterloo01 | |
17/5/2017 08:41 | Thanks football, a very concise message from RP. Clearly the market was anticipating no issues with events leading to this successful Milestone.Hopefully there will soon be some unexpected positive developments to move us forward.Cheers, tightfist | tightfist | |
15/5/2017 16:05 | Summit Therapeutics to receive US$22mln milestone payment as final patient enrols for DMD trial Share 12:59 15 May 2017 | football | |
15/5/2017 12:46 | AIM will take its lead from nasdaq this pm. | luminoso |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions